Patent ID: 6384064
Filing Date: 2002-05-07
Classification: A61K,A61P,Y02A

Abstract:
A method of inhibiting infection by a virus comprising administering to a patient in need thereof a therapeutically effective amount of a (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or a (5-aryl-1,2,4-thiadiazol)-3-yl urea derivative having the formula: wherein,X is oxygen or sulfur; R is hydrogen or alkyl having from 1 to 3 carbon atoms; n is 0 to 4; and R1 is independently selected from the group consisting of hydrogen, alkyl having from 1 to 7 carbon atoms, chloro, bromo, fluoro, oxychloro, and alkoxy having the formula â€”O(CH2)yCH3 wherein y is from 1 to 6; for a period of time sufficient to build up immunity to infection with said virus.